Search results for “Hypereosinophilic syndrome” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 216 patents, we discovered top 52 key players by total patent application. Deciphera Pharmaceuticals, Inc., Novartis AG, Glaxosmithkline Intellectual Property Development Ltd. are dominant in this area. They take 46.76% of the total patent filing.
Deciphera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 57
Novartis AG
Basel-Stadt, Switzerland
Patent: 26
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
STARTUP
Alkahest, Inc.
California, United States
Patent: 13
Topigen Pharmaceuticals, Inc.
Quebec, Canada
Patent: 6
Nippon Zoki Pharmaceutical Co. Ltd.
Osaka-fu, Japan
Patent: 6
Pharmaxis Ltd.
Queensland, Australia
Patent: 5
GlaxoSmithKline LLC
Pennsylvania, United States
Patent: 5
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 4
Asubio Pharma Co. Ltd.
Japan
Patent: 4
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 14 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Alkahest, Inc.
California, United States
Patent: 13
STARTUP
Areteia Therapeutics, Inc.
New Jersey, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents applied in the last 5 years. We discover 13 most active companies in this area. The fast-growing Glaxosmithkline Intellectual Property Development Ltd., Deciphera Pharmaceuticals, Inc., Blueprint Medicines Corp. take 60.00% of patent filing during this period.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
Deciphera Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 6
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 3
STARTUP
Alkahest, Inc.
California, United States
Patent: 2
GlaxoSmithKline LLC
Pennsylvania, United States
Patent: 2
Vanderbilt University
Tennessee, United States
Patent: 2
ReversPAH LLC
Colorado, United States
Patent: 2
4D Pharma Research Ltd.
Aberdeen City, United Kingdom
Patent: 1
Ajou University Industry-Academic Cooperation Foundation
South Korea
Patent: 1
Cephalon, Inc.
Pennsylvania, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 45 patents in last 5 years, we discover 9 new entrants. Glaxosmithkline Intellectual Property Development Ltd., Blueprint Medicines Corp., ReversPAH LLC are the most active new entrants in this area.
Glaxosmithkline Intellectual Property Development Ltd.
East Sussex, United Kingdom
Patent: 18
Blueprint Medicines Corp.
Massachusetts, United States
Patent: 3
ReversPAH LLC
Colorado, United States
Patent: 2
Vanderbilt University
Tennessee, United States
Patent: 2
4D Pharma Research Ltd.
Aberdeen City, United Kingdom
Patent: 1
Landos Biopharma, Inc.
Virginia, United States
Patent: 1
Apollon, Inc.
Pennsylvania, United States
Patent: 1
Ajou University Industry-Academic Cooperation Foundation
South Korea
Patent: 1
Kaijie (Suzhou) Translational Medicine Research Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 23 patents, we discovered top 6 universities and scientific research institutions by total patent application. Université Libre de Bruxelles, Université Catholique de Louvain, Vanderbilt University are dominant in this area. They take 43.48% of the total patent filing.
Université Libre de Bruxelles
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 4
Université Catholique de Louvain
Vlaams-Brabant, Belgium
Patent: 4
Vanderbilt University
Tennessee, United States
Patent: 2
National Yang Ming University
Taiwan Province, China
Patent: 2
National Tsing-Hua University
Taiwan Province, China
Patent: 1
University of Chile
Chile
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: